Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET

Journal of Biological Chemistry

Volumn 289, Issue 16, 2014, Pages 11068-11082

  Vogel, Sebastian ^a   Chatterjee, Madhumita ^a   Metzger, Katja ^a   Borst, Oliver ^a   Geisler, Tobias ^a   Seizer, Peter ^a   Müller, Iris ^a   Mack, Andreas ^a   Schumann, Susanne ^a   Bühring, Hans Jörg ^a   Lang, Florian ^a   Sorg, Rüdiger V ^b   Langer, Harald ^a   Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; HEART; REPAIR;

ACTIVATED PLATELETS; CARDIAC MYOCYTES; DOWN-REGULATION; HEPATOCYTE GROWTH FACTOR RECEPTOR; HIGH-MOBILITY GROUPS; MESENCHYMAL STEM CELL; MOLECULAR MECHANISM; MYOCARDIAL INJURY;

PLATELETS;

HIGH MOBILITY GROUP B1 PROTEIN; SCATTER FACTOR RECEPTOR; TOLL LIKE RECEPTOR 4;

APOPTOSIS; ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; TISSUE REPAIR;

CARDIAC REPAIR AND REGENERATION; CELL MIGRATION; HMGB1; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; PLATELETS; TOLL-LIKE RECEPTORS (TLR);

APOPTOSIS; BLOOD PLATELETS; CELL MOVEMENT; DOWN-REGULATION; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HMGB1 PROTEIN; HUMANS; MESENCHYMAL STROMAL CELLS; MYOCARDIUM; MYOCYTES, CARDIAC; PLATELET ACTIVATION; PROTO-ONCOGENE PROTEINS C-MET; REGENERATION; TOLL-LIKE RECEPTOR 4;

EID: 84898966259     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.530287     Document Type: Article

References (59)

1. Ertl, G., and Frantz, S. (2005) Healing after myocardial infarction. Cardiovasc. Res. 66, 22-32
2. Frangogiannis, N. G., Smith, C. W., and Entman, M. L. (2002) The inflammatory response in myocardial infarction. Cardiovasc. Res. 53, 31-47
3. Pfeffer, M. A., and Braunwald, E. (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81, 1161-1172
4. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317
5. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147
6. Wen, Z., Zheng, S., Zhou, C., Wang, J., and Wang, T. (2011) Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J. Cell Mol. Med. 15, 1032-1043
7. Wollert, K. C., and Drexler, H. (2005) Mesenchymal stem cells for myocardial infarction: promises and pitfalls. Circulation 112, 151-153
8. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697-705
9. Lee, C. H., Shah, B., Moioli, E. K., and Mao, J. J. (2010) CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J. Clin. Invest. 120, 3340-3349
10. Li, J. H., Zhang, N., and Wang, J. A. (2008) Improved anti-Apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J. Endocrinol. Invest. 31, 103-110
11. Mias, C., Lairez, O., Trouche, E., Roncalli, J., Calise, D., Seguelas, M. H., Ordener, C., Piercecchi-Marti, M. D., Auge, N., Salvayre, A. N., Bourin, P., Parini, A., and Cussac, D. (2009) Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 27, 2734-2743
12. Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., and Dzau, V. J. (2005) Paracrine action accounts for marked protection of ischemic heart by Aktmodified mesenchymal stem cells. Nat. Med. 11, 367-368
13. Gnecchi, M., Zhang, Z., Ni, A., and Dzau, V. J. (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103, 1204-1219
14. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang, J. Q., Stewart, G., Lehrke, S., Baumgartner, W. W., Martin, B. J., Heldman, A. W., and Hare, J. M. (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 102, 11474-11479
15. Chen, S. L., Fang, W. W., Ye, F., Liu, Y. H., Qian, J., Shan, S. J., Zhang, J. J., Chunhua, R. Z., Liao, L. M., Lin, S., and Sun, J. P. (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92-95
16. Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Uematsu, M., Yamagishi, M., Mori, H., Kangawa, K., and Kitamura, S. (2004) Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am. J. Physiol. Heart Circ. Physiol. 287, H2670-H2676
17. Assmus, B., Honold, J., Schächinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., Teupe, C., Pistorius, K., Martin, H., Abolmaali, N. D., Tonn, T., Dimmeler, S., and Zeiher, A. M. (2006) Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232
18. Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., and Drexler, H. (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148
19. Vogel, S., Trapp, T., Börger, V., Peters, C., Lakbir, D., Dilloo, D., and Sorg, R. V. (2010) Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells. Cell Mol. Life Sci. 67, 295-303
20. Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., and Sasayama, S. (1997) Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 95, 2552-2558
21. Zhu, Y., Hojo, Y., Ikeda, U., and Shimada, K. (2000) Production of hepatocyte growth factor during acute myocardial infarction. Heart 83, 450-455
22. Xiao, G. H., Jeffers, M., Bellacosa, A., Mitsuuchi, Y., Vande Woude, G. F., and Testa, J. R. (2001) Anti-Apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-Activated protein kinase pathways. Proc. Natl. Acad. Sci. U.S.A. 98, 247-252
23. Aoki, M., Morishita, R., Taniyama, Y., Kida, I., Moriguchi, A., Matsumoto, K., Nakamura, T., Kaneda, Y., Higaki, J., and Ogihara, T. (2000) Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther. 7, 417-427
24. Okunishi, K., Dohi, M., Nakagome, K., Tanaka, R., Mizuno, S., Matsumoto, K., Miyazaki, J., Nakamura, T., and Yamamoto, K. (2005) A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 175, 4745-4753
25. Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., and Matsuda, H. (2000) Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest. 106, 1511-1519
26. Gawaz, M., and Vogel, S. (2013) Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood 122, 2550-2554
27. Borst, O.,Münzer, P., Gatidis, S., Schmidt, E. M., Schönberger, T., Schmid, E., Towhid, S. T., Stellos, K., Seizer, P., May, A. E., Lang, F., and Gawaz, M. (2012) The inflammatory chemokineCXCmotif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ. Res. 111, 1297-1307
28. Fitzgerald, D. J., Roy, L., Catella, F., and FitzGerald, G. A. (1986) Platelet activation in unstable coronary disease. N. Engl. J. Med. 315, 983-989
29. Gawaz, M., Langer, H., and May, A. E. (2005) Platelets in inflammation and atherogenesis. J. Clin. Invest. 115, 3378-3384
30. Trip, M. D., Cats, V. M., van Capelle, F. J., and Vreeken, J. (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 322, 1549-1554
31. Willerson, J. T., Golino, P., Eidt, J., Campbell, W. B., and Buja, L. M. (1989) Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 80, 198-205
32. Andersson, U., and Tracey, K. J. (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29, 139-162
33. Erlandsson Harris, H., and Andersson, U. (2004) Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34, 1503-1512
34. Rouhiainen, A., Imai, S., Rauvala, H., and Parkkinen, J. (2000) Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb. Haemost. 84, 1087-1094
35. Kohno, T., Anzai, T., Naito, K., Miyasho, T., Okamoto, M., Yokota, H., Yamada, S., Maekawa, Y., Takahashi, T., Yoshikawa, T., Ishizaka, A., and Ogawa, S. (2009) Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc. Res. 81, 565-573
36. Andrassy, M., Volz, H. C., Igwe, J. C., Funke, B., Eichberger, S. N., Kaya, Z., Buss, S., Autschbach, F., Pleger, S. T., Lukic, I. K., Bea, F., Hardt, S. E., Humpert, P. M., Bianchi, M. E., Mairbäurl, H., Nawroth, P. P., Remppis, A., Katus, H. A., and Bierhaus, A. (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117, 3216-3226
37. Kitahara, T., Takeishi, Y., Harada, M., Niizeki, T., Suzuki, S., Sasaki, T., Ishino, M., Bilim, O., Nakajima, O., and Kubota, I. (2008) High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc. Res. 80, 40-46
38. Oozawa, S., Mori, S., Kanke, T., Takahashi, H., Liu, K., Tomono, Y., Asanuma, M., Miyazaki, I., Nishibori, M., and Sano, S. (2008) Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ. J. 72, 1178-1184
39. Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J. Y., Strassheim, D., Sohn, J. W., Yamada, S., Maruyama, I., Banerjee, A., Ishizaka, A., and Abraham, E. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 290, C917-C924
40. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. Y., Strassheim, D., Ishizaka, A., and Abraham, E. (2004) Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377
41. Kume, S., Kato, S., Yamagishi, S., Inagaki, Y., Ueda, S., Arima, N., Okawa, T., Kojiro, M., and Nagata, K. (2005) Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J. Bone Miner. Res. 20, 1647-1658
42. Pevsner-Fischer, M., Morad, V., Cohen-Sfady, M., Rousso-Noori, L., Zanin-Zhorov, A., Cohen, S., Cohen, I. R., and Zipori, D. (2007) Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109, 1422-1432
43. Gawaz, M., Neumann, F. J., Dickfeld, T., Koch, W., Laugwitz, K. L., Adelsberger, H., Langenbrink, K., Page, S., Neumeier, D., Schömig, A., and Brand, K. (1998) Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98, 1164-1171
44. Stellos, K., Bigalke, B., Stakos, D., Henkelmann, N., and Gawaz, M. (2010) Platelet-bound P-selectin expression in patients with coronary artery disease. Impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication. J. Thromb. Haemost. 8, 205-207
45. Vogel, S., Peters, C., Etminan, N., Börger, V., Schimanski, A., Sabel, M. C., and Sorg, R. V. (2013) Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment. Biochem. Biophys. Res. Commun. 431, 428-432
46. Gerczuk, P. Z., and Kloner, R. A. (2012) An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J. Am. Coll. Cardiol. 59, 969-978
47. Britten, M. B., Abolmaali, N. D., Assmus, B., Lehmann, R., Honold, J., Schmitt, J., Vogl, T. J., Martin, H., Schächinger, V., Dimmeler, S., and Zeiher, A. M. (2003) Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108, 2212-2218
48. Langer, H., May, A. E., Daub, K., Heinzmann, U., Lang, P., Schumm, M., Vestweber, D., Massberg, S., Schönberger, T., Pfisterer, I., Hatzopoulos, A. K., and Gawaz, M. (2006) Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ. Res. 98, e2-e10
49. Langer, H. F., Stellos, K., Steingen, C., Froihofer, A., Schönberger, T., Krämer, B., Bigalke, B., May, A. E., Seizer, P., Müller, I., Gieseke, F., Siegel-Axel, D., Meuth, S. G., Schmidt, A., Wendel, H. P., Bloch, W., and Gawaz, M. (2009) Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. J. Mol. Cell Cardiol. 47, 315-325
50. Massberg, S., Konrad, I., Schürzinger, K., Lorenz, M., Schneider, S., Zohlnhoefer, D., Hoppe, K., Schiemann, M., Kennerknecht, E., Sauer, S., Schulz, C., Kerstan, S., Rudelius, M., Seidl, S., Sorge, F., Langer, H., Peluso, M., Goyal, P., Vestweber, D., Emambokus, N. R., Busch, D. H., Frampton, J., and Gawaz, M. (2006) Platelets secrete stromal cell-derived factor 1-And recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203, 1221-1233
51. Stellos, K., Langer, H., Daub, K., Schoenberger, T., Gauss, A., Geisler, T., Bigalke, B., Mueller, I., Schumm, M., Schaefer, I., Seizer, P., Kraemer, B. F., Siegel-Axel, D., May, A. E., Lindemann, S., and Gawaz, M. (2008) Plateletderived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34-cells to endothelial progenitor cells. Circulation 117, 206-215
52. Nomura, S., Fujita, S., Ozasa, R., Nakanishi, T., Miyaji, M., Mori, S., Ito, T., and Ishii, K. (2011) The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy. Platelets 22, 396-397
53. Tomchuck, S. L., Zwezdaryk, K. J., Coffelt, S. B., Waterman, R. S., Danka, E. S., and Scandurro, A. B. (2008) Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26, 99-107
54. Wang, Y., Abarbanell, A. M., Herrmann, J. L., Weil, B. R., Manukyan, M. C., Poynter, J. A., and Meldrum, D. R. (2010) TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS One 5, e14206
55. Waterman, R. S., Tomchuck, S. L., Henkle, S. L., and Betancourt, A. M. (2010) A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One 5, e10088
56. Müller, I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M. P., Horwitz, E. M., Conte, P., Handgretinger, R., and Dominici, M. (2006) Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8, 437-444
57. Murphy, M. B., Blashki, D., Buchanan, R. M., Yazdi, I. K., Ferrari, M., Simmons, P. J., and Tasciotti, E. (2012) Adult and umbilical cord bloodderived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials 33, 5308-5316
58. Chen, G. Y., and Nuñez, G. (2010) Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837
59. Uccelli, A., Moretta, L., and Pistoia, V. (2008) Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736